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The current climate is one of uncertainty and immeasurable tragedy for people afflicted by
the pandemic of SARS-CoV-2 virus infection. As professionals, we have a duty of care to-
wards all patients especially the vulnerable and those suffering with life-threatening ill-
nesses such as oral cancer. We present a safe & objective triaging method for afflicted with
this disease in the prevailing morbid situation.
Crown Copyright © 2020 Published by Elsevier Ltd on behalf of Royal College of Surgeons of
Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. All
rights reserved.Introduction
Since the advent of the pandemic of SARS-CoV-2 infection
(COVID-19), a number of changes have ensued in terms of
patient assessment & management. It is apparent that the
care of the elderly and vulnerable patients has been severely
compromised. Amongst them are the head & neck oncology
patients who need regular and rigorous evaluation to ensure
that new and/or recurrent pathologies are not missed & that
their anxiety is alleviated.
Many units across United Kingdom (UK) & other countries
have devised alternative arrangements in the form of remote
or virtual clinics including telephone and/or video consulta-
tions to provide continuity of care so that these patients do not
have to attend high-risk environments such as hospitals &
surgeries and hence prevent spread of disease. Although,
avoiding face-to-face (F2F) reviews has proven advantages in
the present scenario, there is increased anxiety amongstSurgery Department, Bar
mtaz).
ed by Elsevier Ltd on be
geons in Ireland. All rightsurgeons due to the uncertainty and fear of missing cancer
diagnosis using remote aids.
The British Association of Head & Neck Oncology (BAHNO)
issued a joint statement along with the Ear, Nose & Throat UK
(ENT UK) and British Association of Oral & Maxillofacial Sur-
geons (BAOMS) in March 2020, recommending an urgent need
for rigorous triaging of referrals & follow-ups, significantly
reducing surgical work-load and provisioning of alternative &
less extensive modes of surgery & reconstruction when
required.1Methods
In view of the above recommendations, The Oral and Maxillo-
facial Surgery team at South West Head & Neck Institute
developed a triaging system based on the risk of recurrence as
well as the risk of survival if patient contracted COVID-19.net Hospital, Wellhouse Lane, London EN5 3DJ, United Kingdom.
half of Royal College of Surgeons of Edinburgh (Scottish charity
s reserved.





Current smoker and/or heavy alcohol intake
Poor tumour differentiation












No current smoking/heavy alcohol intake
t h e s u r g e on 1 9 ( 2 0 2 1 ) 3 3e3 634The risk of recurrencewas classified into high, intermediate and
low tiers based on well-known prognostic variables (Table 1).
The risk of survival was assessed based on the vulnerability of
the population as specified by the Public Health, England during
the current pandemic (Table 2).2 An algorithm was then con-
structed utilising these variables to safely triage patients who
need F2F assessment as outlined (Table 3).Discussion
A balanced approach for safe triaging & to ascertain the need
for complete assessment of the head& neck oncology patients
is necessary to reduce the risk of spread of infection as well as
to prevent harm to this vulnerable cohort. In many cases, F2F
evaluation remains the only satisfactory option to achieve
adequate assessment and reduce anxiety amongst patients.
The risk factors associated with oral cancer are well
known. A number of factors which heighten the risk of




Pulmonary conditions - Asthma/COPD
Cardiovascular diseases - MI/Heart failure
Chronic kidney disease
Liver diseases - Hepatitis/Cirrhosis
Neurological disorders - Parkinson's disease/Motor
neurone disease/Multiple sclerosis
Immunosuppression due to disease/medications/cancer
treatment
BMI >40literature.3e5 The chances of patients developing COVID-19 &
it's morbid consequences increase significantly with age,
co-morbidities & immunosuppression. Needless to say, the
patients in the ‘vulnerable category’ have been advised to
‘shield’ themselves for up to 12 weeks to prevent contagion &
it's sequelae.6 It is therefore, counterproductive to bring these
patients for F2F review without risk stratification and triaging
except in emergency situations.
We understand that algorithms have their limitations such
as being complex, time consuming & associated difficulties
with compliance. However, for many clinicians this will be a
valuable tool which would provide an objective method of
triaging and hence reducing the risk significantly in this
vulnerable population. In our unit, we have successfully used
the algorithm for our patients with encouraging results. Local
modifications may be required to assimilate the working
pattern of different units. The authors hope that this novel
risk stratification & triaging algorithm will be useful in the
head and neck surgery units promoting safe practice aswell as
preventing harm to the patients.D-19.
Vulnerable population
Solid organ recipients
Patient having active chemotherapy
Patients undergoing radical radiotherapy
Patients with haematological malignancies - Leukaemia/Lymphoma/
Myeloma & history of bone marrow transplant in the last 6 months
Patient having immunotherapy
Patients undergoing targets cancer treatments
Pregnant women with significant congenital or acquired
cardiovascular disease
Patients with severe respiratory conditions - Cystic fibrosis/Severe
Asthma/Severe COPD
Patents with rare diseases & inborn errors of metabolism
Table 3 e Triaging algorithm for head and neck oncology patients.
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